Background Etanercept and methotrexate are effective in the treatment of rheumatoid arthritis
but no data exist on concurrent initiation or use of the combination compared with either …

Objective The long‐term safety of therapeutic agents that neutralize tumor necrosis factor (TNF)
is uncertain. Recent evidence based on spontaneous reporting shows an association …

Objective To assess the effects of the prescription formulation of glucosamine sulfate (1,500
mg administered once daily) on the symptoms of knee osteoarthritis (OA) during a 6‐month …

Objectives: To develop an ultrasound enthesis score and to assess its validity in the diagnostic
classification of the spondyloarthropathies (SpAs). Methods: Twenty-five patients with …

Objective. To analyse the clinical relevance of the production of anti-infliximab antibodies (anti-infliximab
Abs) in patients with RA undergoing infliximab treatment over a prolonged …

Objective In patients with active rheumatoid arthritis (RA) despite methotrexate, to compare
the efficacy of adding tocilizumab to that of switching to tocilizumab monotherapy. Methods …

Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA)
by an evidence based medicine and expert opinion approach. Methods: The literature …

Background Aiming at therapeutic targets has reduced the risk of organ failure in many
diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid …

Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …